This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Government,
Criminal

Nov. 23, 2020

How will the federal government handle psychedelics?

Psychedelic drugs, such as psilocybin mushrooms, ayahuasca and peyote, are federally illegal. Nevertheless, over the next few years, states across the United States will pass laws creating regulated markets for therapeutic, and possibly even recreational, use of psychedelic drugs and in particular, psilocybin.

Griffen Thorne

Harris Bricken

Griffen focuses his practice on corporate, transactional, intellectual property, data security, regulatory, and litigation matters across a wide variety of domestic and international industries.

Psychedelic drugs, such as psilocybin mushrooms, ayahuasca and peyote, are federally illegal. Nevertheless, over the next few years, states across the United States will pass laws creating regulated markets for therapeutic, and possibly even recreational, use of psychedelic drugs and in particular, psilocybin. It remains to be seen whether the federal government will tolerate state-regulated psychedelics markets or strictly enforce federal criminal laws. The best plac...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up